IRIS
POGGIO, FRANCESCA BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.626
AS - Asia 280
NA - Nord America 61
SA - Sud America 41
AF - Africa 7
Totale 5.015
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.614
SG - Singapore 127
CN - Cina 72
VN - Vietnam 61
US - Stati Uniti d'America 48
BR - Brasile 18
HK - Hong Kong 11
AR - Argentina 10
MX - Messico 8
EC - Ecuador 6
ID - Indonesia 4
PY - Paraguay 4
FR - Francia 3
KE - Kenya 3
AT - Austria 2
FI - Finlandia 2
BO - Bolivia 1
BS - Bahamas 1
CA - Canada 1
CO - Colombia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
GB - Regno Unito 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
KZ - Kazakistan 1
LB - Libano 1
MR - Mauritania 1
NI - Nicaragua 1
NL - Olanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.015
Salva come PNG Salva come JPEG
Città #
Genoa 1.933
Genova 1.853
Rapallo 404
Vado Ligure 388
Singapore 43
Beijing 32
Bordighera 22
Ho Chi Minh City 22
Hanoi 17
Hong Kong 11
New York 10
Ashburn 9
Agawam 7
Mexico City 5
São Paulo 5
Rome 4
Tianjin 4
Hải Dương 3
Ninh Bình 3
Paris 3
Asunción 2
Biên Hòa 2
Curitiba 2
Guayaquil 2
Haiphong 2
Lappeenranta 2
Los Angeles 2
Orem 2
Quito 2
San Justo 2
Santa Clara 2
Thái Nguyên 2
Verona 2
Vũng Tàu 2
Acolman 1
Almaty 1
Almirante Tamandaré 1
Arafat 1
Araguaiana 1
Bandar Lampung 1
Boca Toma 1
Buenos Aires 1
Bình Dương 1
Bắc Giang 1
Camden 1
Caracas 1
Caruaru 1
Chalco 1
Chennai 1
Chicago 1
City of London 1
Cochabamba 1
Córdoba 1
Da Nang 1
Dakar 1
Detroit 1
Goya 1
Guangzhou 1
Hangzhou 1
Havana 1
Iporã 1
Jakarta 1
Katueté 1
Lanús 1
Machala 1
Managua 1
Mariana 1
Medford 1
Minya 1
Mountain View 1
Nairobi 1
Nasiriyah 1
Nassau 1
Orlando 1
Paraná 1
Phoenix 1
Phủ Lý 1
Porto Real do Colégio 1
Posadas 1
Quảng Ninh 1
Reconquista 1
Rio de Janeiro 1
Riobamba 1
Ružomberok 1
Santa Rita 1
Santo Domingo 1
Seattle 1
Sincelejo 1
Sousa 1
Thái Bình 1
Tláhuac 1
Tokyo 1
Valença 1
Viamão 1
Vienna 1
Voluntari 1
Votorantim 1
Vredenburg 1
Xinxiang 1
Yên Bái 1
Totale 4.872
Salva come PNG Salva come JPEG
Nome #
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis 197
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 179
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 174
Management of young women with early breast cancer 166
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of Fc gamma RIIIA/Fc gamma RIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 161
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 151
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 149
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials 149
Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient–level data 149
News on the medical treatment of young women with early-stage HER2-negative breast cancer 147
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 143
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 143
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 140
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients 138
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 138
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 131
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 131
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 130
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 130
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 129
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 127
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects 127
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 116
Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do? 115
Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer 111
Role of dose-dense chemotherapy in high-risk early breast cancer 111
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial 111
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 106
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis 101
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 99
Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis 89
Fertility counseling of young breast cancer patients 86
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 81
"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper" 73
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials 72
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world 70
Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: (ESMO Open (2021) 6(2), (S2059702921000089), (10.1016/j.esmoop.2021.100054)) 65
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 62
Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered? 62
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial 62
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial 59
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria 58
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study 56
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 55
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies 48
Different activity and toxicity of immunotherapy in monozygotic twins diagnosed with early triple-negative breast cancer: a case report 45
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study 33
null 27
Totale 5.202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.477
article - articoli 18.477
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 38 16 39 17 45 19 33
2021/2022403 15 16 26 50 14 43 10 86 42 39 12 50
2022/2023478 46 51 6 54 71 73 10 38 68 2 57 2
2023/2024287 11 29 4 49 23 21 23 20 15 18 23 51
2024/20251.236 45 74 27 57 134 138 123 250 77 68 125 118
2025/20261.220 255 112 305 197 291 60 0 0 0 0 0 0
Totale 5.202